Drug-labels.com

Gabapentin (Apotex): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
800 mg, 600 mg, 300 mg, 100 mg, 400 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Gabapentin (Apotex)

ABOUT THIS MEDICATION

What the medication is used for:

GABAPENTIN (gabapentin) belongs to the family of medicines called antiepileptic drugs and is used for treating epilepsy (seizures).

What it does:

GABAPENTIN has been prescribed for you by your doctor to reduce your number of seizures.

When it should not be used:

Do not use GABAPENTIN if you are allergic to it or any of the components in the formulation (see list of components under nonmedicinal ingredients). Stop taking the drug and contact your doctor immediately if you experience an allergic reaction or any severe or unusual side effects while taking the drug.

What the medicinal ingredient is:

Gabapentin

What the important nonmedicinal ingredients are:

GABAPENTIN capsules contain the following non-medicinal ingredients: magnesium stearate, sodium croscarmellose and talc. The hard gelatin capsule shells contain edible blue ink, gelatin, red iron oxide (400 mg capsules only), silicon dioxide, sodium lauryl sulphate, titanium dioxide, and yellow iron oxide (300 and 400 mg capsules only).

GABAPENTIN tablets contain the following non-medicinal ingredients: copovidone, hydroxypropyl cellulose, hydroxypropyl methylcellulose, magnesium stearate, polyethylene glycol, purified water and titanium dioxide.

What dosage forms it comes in:

GABAPENTIN is available in both capsules (containing 100 mg, 300 mg and 400 mg of gabapentin) and in tablets (containing 600 mg or 800 mg of gabapentin).

WARNINGS AND PRECAUTIONS

BEFORE you use GABAPENTIN tell your doctor or pharmacist:

  • All your medical conditions, especially if you have any kidney disease.
  • If you are taking any other medicines

    (prescription and nonprescription).

  • If you have ever had an allergic reaction to medication, food, etc.
  • If you are pregnant or thinking about becoming pregnant.

  • If you are breast-feeding.
  • Your habits of alcohol consumption.
  • If you drive a vehicle or perform hazardous tasks during your work.

It is important for your doctor to have all of the above information before prescribing treatment and dosage.

INTERACTIONS WITH THIS MEDICATION

Tell your doctor if you start or stop taking morphine. Morphine may increase the levels of GABAPENTIN in your blood. If you experience increased side effects such as drowsiness or slowed breathing while taking these drugs together, the dose of GABAPENTIN or morphine may need to be adjusted.

PROPER USE OF THIS MEDICATION

Usual dose:

  • It is very important that you take

    GABAPENTIN exactly as your doctor has instructed.

  • GABAPENTIN may be taken with or without food.

  • You should not increase or decrease the amount of GABAPENTIN you are taking unless your doctor tells you to.
  • Do not stop taking it abruptly because your

    seizures may increase.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

If you have taken a large number of tablets or capsules all at once, contact your doctor or nearest hospital emergency department, even though you may not feel sick. Show the doctor your bottle of medication.

Missed Dose:

If you miss a dose, take it as soon as possible. However, if it is within 4 hours of your next dose do not take the missed dose and return to your regular dosing schedule. Do not allow more than 12 hours to go by between doses because your seizures may increase. If that happens, consult your doctor as soon as possible.

REMINDER: This medicine has been prescribed only for you. Do not give it to anybody else, as they may experience undesirable effects, which may be serious.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

This is not a complete list of side effects. For any unexpected effects while taking GABAPENTIN, contact your doctor or pharmacist.

Like all medications, GABAPENTIN can cause some side effects. You may not experience any of them. For most patients these side effects are likely to be minor and temporary. However, some may be serious. Some of these side effects may be dose related. Consult your doctor if you experience these or other side effects, as the dose may need to be adjusted.

  • Call your doctor immediately if your

    seizures get worse.

  • Stop taking the drug and contact your doctor

    immediately if you experience any severe, unusual or allergic reactions (including skin rash or redness and/or breathing difficulties).

  • When you first begin taking GABAPENTIN

    you may experience some side effects such as drowsiness, dizziness, lack of muscle coordination, and fatigue. Consult your doctor if you experience any of these, as the dose may have to be adjusted.

    • If your epilepsy is not controlled, it is very important not to perform any potentially hazardous tasks, such as driving a car or operating dangerous machines. If your epilepsy is controlled, it is important to refrain from potentially dangerous tasks until you are sure this medication does not affect your mental alertness or physical coordination.
    • Avoid alcoholic drinks while taking

      GABAPENTIN.

    • The following side effects have been reported since gabapentin has been marketed. At this time it is unknown whether or not these side effects were caused by the use of gabapentin. If you develop any of the following side effects tell your doctor immediately: skin rash or redness, blood glucose fluctuations for patients suffering from diabetes, chest pain, shortness of breath, hallucinations, unusual muscle movement or tone, heart

      palpitations, ringing or whistling in the ear, unusual changes in mood, sleeplessness, jaundice (yellowing of skin), dark urine, nausea and/or vomiting, swelling of legs, ankles or feet, and inability to control urination.

    • Please see your doctor immediately if you develop fever, rash, swollen lymph nodes, hives, sore mouth, sore eyes or swelling of lips or tongue, particularly in the first six weeks of therapy.
    • If you have suicidal thoughts while taking

      GABAPENTIN, you should seek immediate medical assistance.

    • The following side effects have been reported when gabapentin is abruptly stopped: anxiety, sleeplessness, nausea, pain, and sweating.
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and seek immediate emergency medical attention

Only if

severe

In all cases
CommonSwelling of legs, ankles or feet.
Uncommon

Heart

palpitations

Chest pains
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM

Jaundice

(yellowing of skin)

Dark urine

Unusual

muscle

movement or tone

Hallucinations
Unusual changes in mood
Shortness of breath
Seizures

Severe,

unusual or allergic

reactions

(fever, rash, swollen

lymph nodes, hives, sore mouth, sore eyes or

swelling of lips or tongue)

This is not a complete list of side effects. For any unexpected effects while taking GABAPENTIN, contact your doctor or pharmacist.

HOW TO STORE IT

  • Capsules: Store at room temperature

    15-30°C (59-86°F), in tightly closed and light resistant containers.

  • Tablets: Store at room temperature 15-30°C

    (59-86°F). Protect from moisture.

  • Do not use this medicine after the expiry

    date, which is printed on the package label.

  • If your doctor tells you to stop taking

    GABAPENTIN, or if you find that they have passed their expiry data, please return any leftover medicine to you pharmacist.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

For more information, please contact your doctor, pharmacist or other healthcare professional.

This leaflet plus the full product monograph, prepared for health professionals, can be obtained by contacting DISpedia, Apotex's Drug Information Service at:

1-800-667-4708

This leaflet can also be found at:

http://www.apotex.ca/products.

M9L 1T9.

Last revised: March 14, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02403757

Revision date stated in the text: March 14, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Gabapentin (Apotex)

Rx or OTC
Prescription (Rx)?
DIN 02403757, 02403765, 02403773, 02403781, 02403803
Schedule(s) PRESCRIPTION
Active ingredient(s) Gabapentin
Dosage form(s) Tablet, Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02B Other analgesics and antipyretics
        1. N02BF01 Gabapentin
Company APOTEX INC
Current status Approved
Current status date March 26, 2013
Strengths and forms
DIN Strength Dosage form(s) Current status
02403757 800 MG Tablet Approved March 26, 2013
02403765 600 MG Tablet Approved March 26, 2013
02403773 300 MG Capsule Approved March 26, 2013
02403781 100 MG Capsule Approved March 26, 2013
02403803 400 MG Capsule Approved March 26, 2013

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.